Elevation Oncology Statistics
Total Valuation
TSX:YRB has a market cap or net worth of CAD 16.16 million. The enterprise value is 13.58 million.
Market Cap | 16.16M |
Enterprise Value | 13.58M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSX:YRB has 461.59 million shares outstanding. The number of shares has increased by 5.93% in one year.
Current Share Class | 461.59M |
Shares Outstanding | 461.59M |
Shares Change (YoY) | +5.93% |
Shares Change (QoQ) | +11.66% |
Owned by Insiders (%) | 29.54% |
Owned by Institutions (%) | n/a |
Float | 325.21M |
Valuation Ratios
The trailing PE ratio is 1.91.
PE Ratio | 1.91 |
Forward PE | n/a |
PS Ratio | 349.69 |
PB Ratio | 0.49 |
P/TBV Ratio | 0.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 1.63 |
EV / Sales | 293.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.51 |
Financial Position
The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.00.
Current Ratio | 6.01 |
Quick Ratio | 5.38 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -25.45 |
Financial Efficiency
Return on equity (ROE) is 28.88% and return on invested capital (ROIC) is -3.11%.
Return on Equity (ROE) | 28.88% |
Return on Assets (ROA) | -3.03% |
Return on Invested Capital (ROIC) | -3.11% |
Return on Capital Employed (ROCE) | -4.33% |
Revenue Per Employee | 11,550 |
Profits Per Employee | 2.08M |
Employee Count | 4 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 1.02 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 44.20 |
Average Volume (20 Days) | 82,176 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:YRB had revenue of CAD 46,200 and earned 8.32 million in profits. Earnings per share was 0.02.
Revenue | 46,200 |
Gross Profit | -69,993 |
Operating Income | -1.44M |
Pretax Income | 8.32M |
Net Income | 8.32M |
EBITDA | -1.43M |
EBIT | -1.44M |
Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 2.61 million in cash and 30,710 in debt, giving a net cash position of 2.58 million or 0.01 per share.
Cash & Cash Equivalents | 2.61M |
Total Debt | 30,710 |
Net Cash | 2.58M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 33.29M |
Book Value Per Share | 0.07 |
Working Capital | 2.84M |
Cash Flow
In the last 12 months, operating cash flow was -1.37 million and capital expenditures -1.10 million, giving a free cash flow of -2.47 million.
Operating Cash Flow | -1.37M |
Capital Expenditures | -1.10M |
Free Cash Flow | -2.47M |
FCF Per Share | -0.01 |
Margins
Gross margin is -151.50%, with operating and profit margins of -3,124.73% and 17,998.54%.
Gross Margin | -151.50% |
Operating Margin | -3,124.73% |
Pretax Margin | 17,998.54% |
Profit Margin | 17,998.54% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSX:YRB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.93% |
Shareholder Yield | n/a |
Earnings Yield | 51.47% |
FCF Yield | -15.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TSX:YRB has an Altman Z-Score of 17.7 and a Piotroski F-Score of 3.
Altman Z-Score | 17.7 |
Piotroski F-Score | 3 |